|
ABO |
AS |
NT |
|||
|
O |
41.7-46.8% (44.2%) |
42.9-49.0% (45.9%) |
|||
|
A |
33.7-38.6% (36.2%) |
32.7-38.5% (35.6%) |
|||
|
B |
9.7-12.9% (11.3%) |
9.0-12.8% (10.9%) |
|||
|
AB |
6.9-9.8% (8.3%) |
5.9-9.1% (7.5%) |
|
ABO |
AS |
NT |
|||
|
O |
42.3-47.5% (44.9%) |
42.8-49.2% (46.0%) |
|||
|
A |
33.4-38.4% (35.9%) |
33.2-39.4% (36.3%) |
|||
|
B |
9.5-12.7% (11.1%) |
9.1-13.1% (11.1%) |
|||
|
AB |
6.6-9.5% (8.1%) |
5.0-8.2% (6.6%) |
|
ABO |
AS |
NT |
|||
|
O |
12.3-36.7% (24.5%) |
36.1-54.8% (45.5%) |
|||
|
A |
28.9-56.9% (42.9%) |
21.4-38.6% (30.0%) |
|||
|
B |
5.9-26.8% (16.3%) |
3.7-14.5% (9.1%) |
|||
|
AB |
5.9-26.8% (16.3%) |
8.7-22.2% (15.5%) |